NO2019010I1
(en )
2019-03-01
Eravacycline or pharmaceutically acceptable salts thereof
NO2020037I1
(en )
2020-11-16
alpelisib or a pharmaceutically acceptable salt thereof
NO2019024I1
(en )
2019-05-20
Brigatinib or a pharmaceutically acceptable salt thereof
NO2020008I1
(en )
2020-04-01
nusinersen or its salts
NO2016014I2
(en )
2016-08-10
ceritinib or pharmaceutically acceptable salts thereof
NO2020042I1
(en )
2020-11-24
Entrektinib or isomers, tautomers, or pharmaceutically acceptable salts thereof
NO2017059I1
(en )
2017-11-13
ribosyclib or a pharmaceutically acceptable salt thereof
NO2020034I1
(en )
2020-09-29
Ozanimod or a pharmaceutically acceptable salt thereof, particularly ozanimod hydrochloride
NO2019042I1
(en )
2019-11-28
Talazoparib, optionally in the form of a pharmaceutically acceptable salt
NO2017033I1
(en )
2017-07-11
baricitinib and pharmaceutically acceptable salts thereof
NO2015014I1
(en )
2015-05-04
Paritaprevir, or a pharmaceutically acceptable salt or ester thereof
NO2015012I1
(en )
2015-05-04
Ombitasvir, or a pharmaceutically acceptable salt thereof
DK2308877T3
(en )
2014-04-22
Imidazopyridine-2-one derivatives
BRPI0919447A2
(en )
2015-12-15
1-amino-2-cyclobutylethylboronic acid derivatives
NL301214I2
(en )
2023-04-19
Lasmiditan and pharmaceutically acceptable salts thereof
DK2275414T3
(en )
2015-06-22
CYCLOPENTYLACRYLAMIDE DERIVATIVES
ATE534634T1
(en )
2011-12-15
2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
DK2380892T3
(en )
2014-06-30
IMIDAZOTHIAZOLD DERIVATIVES WITH PROLINING STRUCTURE
BRPI0921578A2
(en )
2019-09-24
unitemporal vaccines
BRPI0920293A2
(en )
2016-02-16
nacelle
NO2019009I1
(en )
2019-02-20
abemaciclib or pharmaceutically acceptable salts thereof
TH105092B
(en )
2010-11-27
Benzoquinasoline derivatives
TH106414B
(en )
2011-03-15
chair
TH106751B
(en )
2011-03-23
chair
TH100454B
(en )
2010-03-24
chair